Cancer Emergencies · Patient & Caregiver Guide
Tumor Lysis Syndrome
Tumor lysis syndrome can alter blood salts and damage the kidneys or heart. High-risk patients need a prevention and blood-monitoring plan before treatment.
Educational information cannot replace emergency assessment. Hospital treatments below describe clinician decisions, not medicines or procedures to perform yourself. Follow your treating team’s personalised emergency plan.
What is this emergency?
Tumor lysis syndrome (TLS) occurs when many cancer cells break down rapidly and release their contents into the blood. It can occur after effective treatment and, less often, before treatment begins.
Why does it happen?
Potassium, phosphate and uric acid may rise, while calcium may fall. These changes can impair kidney function and trigger abnormal heart rhythms or seizures. A good cancer response does not make these complications harmless.
Who is at risk?
Risk is greatest with some fast-growing leukemias and lymphomas, high tumour burden and very treatment-sensitive cancers. Selected targeted treatments also carry risk. Existing kidney disease, dehydration or abnormal baseline tests increase concern; some solid cancers can be affected too.
Early symptoms
Nausea, vomiting, weakness, cramps, tingling, reduced urine or unusual tiredness may occur. Early TLS can have no obvious symptoms, which is why planned blood tests are essential.
Emergency warning signs
Palpitations, collapse, seizures, confusion, severe muscle weakness, breathlessness or very low urine output require emergency care, particularly around a new treatment or dose increase.
What should patients do immediately?
Contact the treatment team immediately for concerning symptoms. Follow the arranged monitoring schedule even if you feel well. Bring your drug list and the date of the last treatment. Emergency symptoms require ambulance or emergency-department assessment.
What should patients avoid?
Do not skip monitoring, alter a dose-escalation schedule, or try to correct blood salts with supplements. Do not force large amounts of fluid when urine output is falling or you have heart or kidney disease. Do not take allopurinol or rasburicase without a prescription.
How is it diagnosed?
Clinicians check potassium, phosphate, calcium, uric acid, creatinine and other relevant blood tests repeatedly. ECG and heart monitoring may be needed. Urine output and fluid balance help identify kidney injury and guide treatment.
How is it treated in hospital?
Hospital care includes tailored hydration, urgent correction of dangerous electrolyte changes and monitoring. Allopurinol reduces formation of new uric acid; rasburicase breaks down existing uric acid in selected patients. G6PD testing is required before rasburicase, which must not be given in G6PD deficiency because of hemolysis and methemoglobinemia risk. Severe kidney injury or refractory abnormalities may require dialysis.
Possible complications
TLS can cause acute kidney failure, arrhythmias, seizures and sudden death. Early laboratory detection may allow treatment before major symptoms develop. Some patients need intensive care.
Prevention and follow-up
Before treatment, ask about TLS risk, preventive medicines, the safe fluid target and exactly when blood tests are required. High-risk treatment may begin in hospital. Follow-up continues until laboratory changes and kidney function are stable; the plan can change with later treatment cycles or dose increases.
Frequently asked questions
Can TLS happen with tablets?
Yes. Some oral targeted treatments can cause rapid cell breakdown and require careful dose escalation and monitoring.
Can I rely on symptoms?
No. Blood-test changes may appear before you feel unwell.
References
References checked on 15 October 2026. Hospital treatment follows local protocols and individual assessment.